https://www.sciencedaily.com/releases/2018/12/181213190606.htm Summary: The findings show for the first time that adults with motor neuron disease taking first-line anti-spasticity drugs who were then treated with an oral spray (nabiximols) containing equal parts delta-9 tetrahydrocannabinol THC and cannabidiol (THC-CBD) experienced less spasticity and pain at 6-week follow-up compared with those given placebo.
ALS by Date
Leafly’s Summary of the Best Research Studies Winter 2018 https://www.leafly.com/news/science-tech/medical-marijuana-research-studies-winter-2018 Studies at a glance: THC Boosts the Efficacy of a Traditional Neuropathic Pain Medication CBD Blocks Toxin’s Ability to Promote Schizophrenia-like Symptoms Cannabis Protects Against Alcohol’s Damaging Effects on the Stomach A Balanced Cannabis Approach May Treat Spasticity in ALS Cannabis Smoke Improves Working Memory…
Have a Question or Comment?
Use our form below. We'll get back to you as soon as we can.